ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Nitrosamines in the Pharmaceutical Industry Regulatory Requirements Training Course | Regulatory, Quality, Sales, and Analytical Functions (ONLINE EVENT: October 13-14, 2025) - ResearchAndMarkets.com

The "The Regulatory Requirements on Nitrosamines in the Pharmaceutical Industry Training Course" training has been added to ResearchAndMarkets.com's offering.

This course will benefit nitrosamine decision makers and those who can benefit from a broader understanding of the full picture of nitrosamines in regulatory affairs, sales, quality, and analytical departments.

Nitrosamine regulations are the most impactful change to our industry in recent years, affecting 30% of current and new products, including generics. Regulatory expectations have changed frequently and vary globally. In this webinar, we will discuss the major requirements and strategies. Those new to the subject and those growing their nitrosamine team will find value in seeing the entire picture. Experienced Small and Medium-sized Enterprises (SMEs) will receive detailed instructions for common pain points, like risk assessments.

Benefits of attending

  • Enhance your understanding of current regulatory framework and recent changes
  • See the full scope of work for your team members to understand how their part fits with the whole
  • Learn best practices for risk assessments
  • Inform next steps when your product is near or above regulatory limits through remediation, control strategies, and new research
  • Example products guide the way to practical understanding

Certification:

  • CPD: 6 hours for your records
  • Certificate of completion

Key Topics Covered:

Day 1

  • History and background
  • Classes of nitrosamines
  • Regulatory update
  • Team building
  • Risk assessments
  • At risk structures
  • Limit determination

Day 2

  • Nitrosation Assay Procedure (NAP) test
  • Analytical instruments and methods
  • Control strategy
  • Remediation
  • Post approval changes
  • Where are we going? Future state and unanswered questions

For more information about this training visit https://www.researchandmarkets.com/r/dzfz8q

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com



For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.